Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reis, A. M.
Right arrow Articles by Friedberg, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reis, A. M.
Right arrow Articles by Friedberg, E. C.
[Cancer Research 60, 1571-1579, March 15, 2000]
© 2000 American Association for Cancer Research


Carcinogenesis

Genotype-specific Trp53 Mutational Analysis in Ultraviolet B Radiation-induced Skin Cancers in Xpc and Xpc Trp53 Mutant Mice1

Antonio M. Reis, David L. Cheo2, Lisiane B. Meira, Marc S. Greenblatt, Jeffrey P. Bond, Dorit Nahari and Errol C. Friedberg3

Laboratory of Molecular Pathology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75235 [A. M. R., D. L.C., L. B. M., D. N., E. C. F.], and Departments of Medicine [M. S. G.] and Microbiology and Molecular Genetics [J. P. B.], University of Vermont College of Medicine, Burlington, Vermont 05405

We have examined the mutational spectrum in the Trp53 gene from UVB radiation-induced skin cancers in Trp53+/+ and Trp53+/- mutant mice of all three possible Xpc genotypes. Mutations were detected in exons 2–10 of the Trp53 coding region in ~90% of >80 different skin cancers examined. In contrast to Trp53+/+ mice in which most mutations in the Trp53 gene were located in exons 5–8, the majority of the mutations in Trp53+/- mice were at other exons. We observed a high predilection for C->T transition mutations at a unique CpG site in codon 122 (exon 4) of the Trp53 gene in Xpc-/- Trp53+/- mice. This site is not part of a pyrimidine dinucleotide. Mutations at this codon, as well as in codons 124 and 210, were observed exclusively in Xpc-/- or Xpc+/- mice. Mutations at the corresponding codons (127 and 213) in the human p53 gene have been reported in skin tumors from human patients with xeroderma pigmentosum. Hence, mutations at codons 122 (125), 124 (127), and 210 (213) may constitute signatures for defective or deficient nucleotide excision repair in mice (humans). In Xpc-/- mice, the majority of mutations were located at C residues in CpG sites, in which the C is presumably methylated. A similar bias can be deduced from studies in human XP individuals.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al.
Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage
Cancer Res., May 15, 2007; 67(10): 4648 - 4656.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. R. Denver, S. Feinberg, C. Steding, M. Durbin, and M. Lynch
The Relative Roles of Three DNA Repair Pathways in Preventing Caenorhabditis elegans Mutation Accumulation
Genetics, September 1, 2006; 174(1): 57 - 65.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. G. Khan, K.-S. Oh, T. Shahlavi, T. Ueda, D. B. Busch, H. Inui, S. Emmert, K. Imoto, V. Muniz-Medina, C. C. Baker, et al.
Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients
Carcinogenesis, January 1, 2006; 27(1): 84 - 94.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. Hoogervorst, W. Bruins, E. Zwart, C. Th.M. van Oostrom, G. J. van den Aardweg, R. B. Beems, J. van den Berg, T. Jacks, H. van Steeg, and A. de Vries
Lack of p53 Ser389 Phosphorylation Predisposes Mice to Develop 2-Acetylaminofluorene-Induced Bladder Tumors but not Ionizing Radiation-Induced Lymphomas
Cancer Res., May 1, 2005; 65(9): 3610 - 3616.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Resnick and A. Inga
Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
PNAS, August 19, 2003; 100(17): 9934 - 9939.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-H. You, P. E. Szabo, and G. P. Pfeifer
Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors
Carcinogenesis, November 1, 2000; 21(11): 2113 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. C. Friedberg
Nucleotide Excision Repair and Cancer Predisposition : A Journey from Man to Yeast to Mice
Am. J. Pathol., September 1, 2000; 157(3): 693 - 701.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.